View in EDS

The RAGE Inhibitor TTP488 (Azeliragon) Improves Diabetic Bladder Dysfunction in Leptin-Deficient Obese Mice.

Saved in:
Bibliographic Details
Title: The RAGE Inhibitor TTP488 (Azeliragon) Improves Diabetic Bladder Dysfunction in Leptin-Deficient Obese Mice.
Authors: Oliveira AL; Department of Pharmacology, Faculty of Medical Sciences, University of Campinas (UNICAMP), Campinas 13084-971, SP, Brazil., Medeiros ML; Department of Pharmacology, Faculty of Medical Sciences, University of Campinas (UNICAMP), Campinas 13084-971, SP, Brazil., Campos ATP; Department of Physics of Federal Ceara, University of Ceara (UFC), Fortaleza 60440-900, CE, Brazil., Cesar CL; Department of Physics of Federal Ceara, University of Ceara (UFC), Fortaleza 60440-900, CE, Brazil., Mónica FZ; Department of Pharmacology, Faculty of Medical Sciences, University of Campinas (UNICAMP), Campinas 13084-971, SP, Brazil., Antunes E; Department of Pharmacology, Faculty of Medical Sciences, University of Campinas (UNICAMP), Campinas 13084-971, SP, Brazil.
Source: Antioxidants (Basel, Switzerland) [Antioxidants (Basel)] 2025 Jun 27; Vol. 14 (7). Date of Electronic Publication: 2025 Jun 27.
Publication Type: Journal Article
Journal Info: Publisher: MDPI AG Country of Publication: Switzerland NLM ID: 101668981 Publication Model: Electronic Cited Medium: Print ISSN: 2076-3921 (Print) Linking ISSN: 20763921 NLM ISO Abbreviation: Antioxidants (Basel) Subsets: PubMed not MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:2076-3921
DOI:10.3390/antiox14070793